Work

Abstract 7075: Preclinical characterization of FHT-171, a first-in-class degrader targeting CREB-binding protein (CBP) in CBP-dependent solid tumors.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-7075

Authors: Darshan Sappal, Molly M. Wilson, Laura La Bonte, Meiyun Lin, Breanna Bullock, Shawn Schiller

Institution: Foghorn Therapeutics (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148759954

Cites:

Cited by:

Related to: